|
End-of-day quote
Shenzhen S.E.
2026-10-19
|
5-day change | 1st Jan Change | ||
| 7.880 CNY | -3.67% |
|
-10.35% | -0.76% |
| Market Cap | 4.58B 685M 611M 566M 515M 966M 64.98B 982M 6.79B 2.67B 33.96B 2.57B 2.52B 109B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.41B 660M 588M 545M 496M 930M 62.59B 945M 6.54B 2.57B 32.71B 2.48B 2.43B 105B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | -3.67% | ||
| 1 week | -10.35% | ||
| Current month | -17.57% | ||
| 1 month | -5.06% | ||
| 3 months | +1.29% | ||
| 6 months | -21.83% | ||
| Current year | -0.76% |
| 1 week | 7.72 | 8.75 | |
| 1 month | 7.72 | 10.43 | |
| Current year | 7.08 | 11.38 | |
| 1 year | 7.08 | 11.38 | |
| 3 years | 3.58 | 11.98 | |
| 5 years | 3.58 | 11.98 | |
| 10 years | 3.58 | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 2017-12-10 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 2019-07-31 |
Sen Li
COO | Chief Operating Officer | 45 | 2022-08-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 2019-07-31 |
Ying Yang
CHM | Chairman | 48 | 2019-03-20 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 2019-03-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.67% | -10.35% | -8.05% | +14.87% | 685M | ||
| -1.33% | +4.88% | +54.50% | +109.94% | 1,106B | ||
| -0.69% | -3.77% | +31.35% | +66.62% | 612B | ||
| -0.96% | +0.55% | +23.13% | +94.26% | 500B | ||
| +0.24% | +5.58% | +33.98% | +59.40% | 367B | ||
| -1.59% | -1.25% | +69.39% | +43.02% | 354B | ||
| -0.40% | +3.53% | +19.17% | +46.55% | 286B | ||
| -0.37% | +3.11% | -1.26% | +18.23% | 256B | ||
| -1.75% | +1.76% | +42.21% | +51.44% | 230B | ||
| -2.00% | +1.75% | +24.64% | +95.14% | 190B | ||
| Average | -1.25% | +1.00% | +28.91% | +59.95% | 390.08B | |
| Weighted average by Cap. | -0.98% | +2.30% | +37.83% | +75.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 147M 131M 121M 110M 207M 13.94B 211M 1.46B 573M 7.29B 552M 540M 23.3B | 1.21B 180M 161M 149M 135M 254M 17.09B 258M 1.79B 702M 8.93B 676M 662M 28.55B |
| Net income | 13.65M 2.04M 1.82M 1.69M 1.53M 2.88M 194M 2.92M 20.22M 7.95M 101M 7.66M 7.5M 323M | 92.73M 13.87M 12.36M 11.45M 10.41M 19.54M 1.31B 19.86M 137M 54.01M 687M 52.03M 50.94M 2.2B |
| Net Debt | 189M 28.27M 25.2M 23.35M 21.23M 39.83M 2.68B 40.49M 280M 110M 1.4B 106M 104M 4.48B | -169M -25.24M -22.5M -20.84M -18.95M -35.56M -2.39B -36.15M -250M -98.31M -1.25B -94.71M -92.73M -4B |
Employees
1,188
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | CN¥7.880 | -3.67% | 33,498,067 |
| 26-10-16 | CN¥8.180 | -1.21% | 43,976,450 |
| 26-10-15 | CN¥8.280 | -0.72% | 35,122,233 |
| 26-10-14 | CN¥8.340 | -3.81% | 22,942,600 |
| 26-10-13 | CN¥8.670 | -1.37% | 25,195,614 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
















